Related Experiment Video
Updated: Apr 16, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Effect and Mechanism of Acacetin Against Stress-Induced Gastric Mucosal Damage: Network Pharmacology, Molecular
Xin-Xin Zhang1, Lin-Yuan Cao2, Fang-Fang Zhang1
1Department of Gastroenterology 363 Hospital Chengdu Sichuan China.
Abstract:
Stress-induced gastric ulcers (SGU) are categorized as a stress-related mucosal disease (SRMD) that exhibits a high morbidity among ICU patients. However, due to the harmful side effects of proton pump inhibitors (PPIs), there is an urgent need for natural and proactive alternative methods in the treatment of SGU. Acacetin, a natural flavonoid, has demonstrated potential in alleviating gastric ulcers. To elucidate the effects of acacetin in SGU, in this study, gastric ulcers (GU)-related targets were retrieved from GeneCards, DisGeNET, and OMIM. A protein-protein interaction (PPI) network was constructed, followed by functional enrichment analyses, including Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. Molecular docking was employed to predict the interactions between acacetin and key target proteins. Furthermore, a cold water-immersion restraint stress (CWIR) induced mouse model was used to validate the protective effects of acacetin on SGU. Network pharmacology and molecular docking revealed that acacetin exerts mucosal protective effects through multiple ferroptosis-related targets. In vivo, acacetin significantly mitigated the loss and disorganization of epithelial cells by inhibiting oxidative stress and ferroptosis, indicating its potential to protect against CWIR-related SGU. Especially, 25 mg/kg/day might be the optimal therapeutic dosage of acacetin as an alternative treatment option for SGU.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

